1. Home
  2. RYAN vs APGE Comparison

RYAN vs APGE Comparison

Compare RYAN & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ryan Specialty Holdings Inc.

RYAN

Ryan Specialty Holdings Inc.

HOLD

Current Price

$32.56

Market Cap

4.1B

Sector

Finance

ML Signal

HOLD

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$86.92

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYAN
APGE
Founded
2010
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
4.7B
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
RYAN
APGE
Price
$32.56
$86.92
Analyst Decision
Buy
Strong Buy
Analyst Count
17
13
Target Price
$50.88
$109.67
AVG Volume (30 Days)
2.2M
867.2K
Earning Date
04-30-2026
05-12-2026
Dividend Yield
1.48%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,051,126,000.00
N/A
Revenue This Year
$15.78
N/A
Revenue Next Year
$12.49
N/A
P/E Ratio
$86.72
N/A
Revenue Growth
21.28
N/A
52 Week Low
$29.28
$34.34
52 Week High
$68.70
$95.32

Technical Indicators

Market Signals
Indicator
RYAN
APGE
Relative Strength Index (RSI) 49.32 54.68
Support Level $31.50 $73.70
Resistance Level $34.41 $86.28
Average True Range (ATR) 1.50 4.94
MACD 0.08 0.78
Stochastic Oscillator 49.26 63.88

Price Performance

Historical Comparison
RYAN
APGE

About RYAN Ryan Specialty Holdings Inc.

Ryan Specialty Holdings Inc is an international specialty insurance intermediary providing specialty products, solutions, and services for insurance brokers, agents, and carriers. The company offers wholesale insurance brokerage and delegated underwriting authority products and services, including distribution, underwriting, product development, administration, and risk management. Its expertise spans property, casualty, professional lines, transportation, personal lines, workers compensation, and employee benefits insurance, across traditional insurance and alternative risk solutions. The company operates in the United States and foreign markets, with the majority of revenue generated from the United States.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks: